本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Pyxis Oncology, Inc.

3.21
-0.0600-1.83%
盤後3.270.0600+1.87%19:42 EDT
成交量:112.95萬
成交額:358.13萬
市值:2.68億
市盈率:-2.29
高:3.42
開:3.31
低:3.07
收:3.27
52周最高:5.55
52周最低:1.03
股本:8,340.81萬
流通股本:4,956.07萬
量比:0.59
換手率:2.28%
股息:- -
股息率:- -
每股收益(TTM):-1.4029
每股收益(LYR):-1.2813
淨資產收益率:-179.10%
總資產收益率:-62.95%
市淨率:23.40
市盈率(LYR):-2.51

資料載入中...

2023/05/24

企業合併公告

Form 425 - Prospectuses and communications, business combinations
2023/05/24

重要事件披露

Form 8-K - Current report
2023/05/24

企業合併公告

Form 425 - Prospectuses and communications, business combinations
2023/05/11

重要事件披露

8-K - Current report
2023/05/11

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2023/05/10

[修訂]年度報告

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/04/04

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2023/03/28

重要事件披露

8-K - Current report
2023/03/23

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/03/22

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2023/03/22

重要事件披露

8-K - Current report
2023/03/22

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/03/16

重要事件披露

8-K - Current report
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/13

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/08

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/12/01

重要事件披露

8-K - Current report